Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
IEEE Transactions on Neural Networks and Learning Systems|October 6, 2020
A Minibatch Proximal Stochastic Recursive Gradient Algorithm Using a Trust-Region-Like Scheme and Barzilai-Borwein StepsizesTengteng Yu, Xin-Wei Liu, Yu-Hong Dai, et al.Cancers|June 11, 2020
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.Antibodies (Basel, Switzerland)|September 25, 2019
Monoclonal Antibody: A New Treatment Strategy against Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.BMC Cancer|November 29, 2017
Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cellsShaowei Qiu, Shuang Liu, Tengteng Yu, et al.Journal for Immunotherapy of Cancer|November 28, 2024
Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case reportWenqiang Yan, Yu Xiong, Rui Lv, et al.Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in ChinaTengteng Yu, Yan Xu, Gang An, et al.Leukemia Research|April 8, 2014
N-Cadherin and Tie2 positive CD34⁺CD38⁻CD123⁺ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID miceShaowei Qiu, Yujiao Jia, Haiyan Xing, et al.Oncotarget|April 13, 2017
FHL2 interacts with iASPP and impacts the biological functions of leukemia cellsWenting Lu, Tengteng Yu, Shuang Liu, et al.Leukemia|February 16, 2020
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myelomaLijie Xing, Liang Lin, Tengteng Yu, et al.Leukemia|August 24, 2018
APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implicationsYu-Tzu Tai, Liang Lin, Lijie Xing, et al.Pageof 3